Page last updated: 2024-11-07

prednisone and Facial Hemiatrophy

prednisone has been researched along with Facial Hemiatrophy in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Facial Hemiatrophy: A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chhabra, A1
Lam, JM1
Rhemus, W1
Goldberg-Stern, H1
deGrauw, T1
Passo, M1
Ball, WS1

Other Studies

2 other studies available for prednisone and Facial Hemiatrophy

ArticleYear
Tongue Involvement in Parry-Romberg Syndrome.
    The Journal of rheumatology, 2017, Volume: 44, Issue:9

    Topics: Adolescent; Atrophy; Child, Preschool; Disease Progression; Facial Hemiatrophy; Female; Glucocortico

2017
Parry-Romberg syndrome: follow-up imaging during suppressive therapy.
    Neuroradiology, 1997, Volume: 39, Issue:12

    Topics: Brain; Child; Facial Hemiatrophy; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Magneti

1997